Chen Ke-Qian, Lei Hai-Bo, Liu Xiang, Wang Shu-Zhi
Department of Clinical Pharmacy, Xiangtan Central Hospital, Xiangtan, 411100, China.
Institute of Pharmacy and Pharmacology, School of Pharmaceutical Sciences, Hengyang Medical School, University of South China, Hengyang, 421001, China.
Heliyon. 2024 Jul 9;10(14):e34362. doi: 10.1016/j.heliyon.2024.e34362. eCollection 2024 Jul 30.
BACKGROUND: E2F7 is a recently discovered member of the E2F family. Investigating the function and mechanism of E2F7 in the growth of tumors is significant for the clinical diagnosis and therapy of these malignancies. OBJECTIVE: The purpose of this review is to provide theoretical basis for the diagnosis and treatment of malignant tumors by exploring E2F7. METHODS: The relevant information was collected through the PubMed database using keyword searches "E2F7" and "cancer". RESULTS: On the one hand, E2F7 plays an essential role in embryonic development, angiogenesis, and the nervous system. On the other hand, E2F7 is also linked to the occurrence and growth of various malignant tumors. CONCLUSION: E2F7 has potential as a therapeutic target in future cancer treatments.
背景:E2F7是E2F家族最近发现的成员。研究E2F7在肿瘤生长中的功能和机制对这些恶性肿瘤的临床诊断和治疗具有重要意义。 目的:本综述旨在通过探索E2F7为恶性肿瘤的诊断和治疗提供理论依据。 方法:通过PubMed数据库使用关键词“E2F7”和“癌症”收集相关信息。 结果:一方面,E2F7在胚胎发育、血管生成和神经系统中起重要作用。另一方面,E2F7也与各种恶性肿瘤的发生和生长有关。 结论:E2F7在未来癌症治疗中具有作为治疗靶点的潜力。
Heliyon. 2024-7-9
Medicine (Baltimore). 2024-1-19
EMBO Rep. 2008-3
Acta Pharmacol Sin. 2025-3-25
Yi Chuan. 2023-7-20
BMC Med Genomics. 2023-2-28
Int J Gen Med. 2022-7-2